Investigator-Initiated, Pilot Translational Study of Circulating Tumor Cells to Identify Predictive Factors of Response to Abiraterone Acetate in Men With Castration-Resistant Prostate Cancer
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jul 2019
Price : $35 *
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Biomarker; Therapeutic Use
- 16 Jul 2019 Planned End Date changed from 1 Oct 2018 to 1 Dec 2019.
- 16 Jul 2019 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated